Stents Market Size, Share, and Trends 2025 to 2034

What is the Stents Market Size?

The global stents market size is accounted at USD 14.50 billion in 2025 and predicted to increase from USD 15.42 billion in 2026 to approximately USD 25.23 billion by 2034, growing at a CAGR of 6.35% from 2025 to 2034. The rising prevalence of chronic diseases like cardiovascular disease and the demand for the minimally invasive surgical procedure for the treatment is driving the growth of the market.

Stents Market Key Takeaways

• By product, the coronary stents segment accounted the biggest market share in 2024.
• By material, the metallic biomaterial segment has dominated the market.
• The metallic materials segment growth of the polymeric bio-materials segment is also expected in the coming years.
• By end user, the hospital segment has emerged as the largest segment.
• By geography, the North America region has emerged as the largest market.

How Can AI Impact the Stents Market?

The integration of artificial intelligence into the healthcare industry has revolutionized the several treatment and diagnostics procedure. The integration of artificial intelligence into the cardiovascular disease helps physicians to determine the most prevalent treatment method for the disease. AI algorithms provide medical personnel real-time guidance and feedback while the cardiovascular disease treatment includes the stent placement and feedback.

• In December 2024, Royal Philips and Mayo Clinic physicians used artificial intelligence to reduce the complex cardiac magnetic resonance imaging exams and enhancing radiology workflow.

What are stents?

Stents are made of plastic or sometimes metal in the form of tiny tubes that are set up into the narrow lumen of the vessel. Various disorders related to the cardiovascular system require the utilization of stents for the correction of the flow of blood through the anatomic vessels and ducts. Various cardiac diseases such as peripheral artery disease, coronary heart disease, and thrombosis of the deep vein require the utilization of stents during the surgical management of the condition.

Increasing demand for minimally invasive surgical procedures for the management of severe diseases is expected to boost the market for instance to a great extent. The adoption of modern technology in the field of medicine has emerged as a major opportunity for the growth of the stents market during the forecast period. A huge number of people all over the world are suffering from cardiovascular diseases and other related disorders of the urinary tract which require the utilization of stents.

Stents Market Growth Factors

As a result of unhealthy lifestyle practices and sedentary habits, the number of patients suffering with cardiovascular disorders has increased gradually. Most of the patients suffering with diseases related to the cardiovascular system belong to the geriatric population. As a result of the lack of movement and exercise among the people belonging to the geriatric population, they are prone to attract cardiovascular disorders. Awareness among the population regarding the various healthcare options and facilities is increasing gradually. This has resulted in an increasing demand for minimally invasive surgical procedures. The utilization of minimally invasive surgical procedures proved to be extremely beneficial for people belonging to the geriatric age group. The wound healing capabilities of the surgical procedures that are conducted with minimally invasive methods are higher as compared to the other traditional methods. The adoption of modern technology in the healthcare system has also boosted the market for stents to a great extent. The outbreak of the pandemic had a positive impact on the growth of the market because of the huge number of patients who were suffering with cardiovascular disorders. A huge number of patients who were affected during the course of the pandemic were seen to be suffering with cardiovascular disorders. The utilization of stents was seen to be increasing rapidly for the various surgical procedures that were carried out on the people.

• The increasing number of people belonging to the geriatric population.
• Unhealthy modern lifestyle practices and sedentary habits.
• Increasing demand for procedures with minimally invasive methods.
• The increasing number of patients suffering with chronic diseases.

Stents Market Outlook

• Industry Growth Overview: The stents market is expected to grow at a steady pace from 2025 to 2030, due to rising cases of cardiovascular disease and the use of minimally invasive surgeries. Moreover, growth in demand for stents will be aided by advances in technology, including bioresorbable and drug-eluting stents—growth will be particularly concentrated in North America and the Asia-Pacific.
• Sustainability trends: Sustainability is transforming the stent market with the use of biodegradable materials, with companies like Abbott and Boston Scientific developing fully bioresorbable polymer stents. Additionally, companies are investing in bioresorbable stents to support global initiatives to reduce medical waste and improve sustainability in the healthcare space.
• Global expansion: The major players in the stents market are expanding into emerging economies to provide affordable cardiac treatment options to a larger number of patients. For example, Medtronic has expanded its capacity to produce in India and China to take advantage of their large patient base and improve supply chain efficiencies.
• Key Investors: Due to high need, margins driven by innovation, and long-term clinical application, private equity firms and healthcare investors are investing in the healthcare space. Investor firms such as Bain Capital and KKR have invested directly in medical device firms centered on interventional cardiology.
• Startup Ecosystem: The startup ecosystem is emerging with emphasis on 3D-printed, patient-specific stents and advanced biomaterials. Startups such as Amaranth Medical and Elixir Medical are garnering VC funding in the space and are both developing next-generation stents that provide enhanced safety and faster healing rates.

Market Scope

Market Dynamics

Key Market Drivers

• Advanced technology - The increasing demand for advanced technology in the field of medical science and healthcare has boosted the demand for stents in the market. The huge number of patients that belonged to the geriatric age group proved to be a driving force for the growth of the stent market. The higher disposable income that is available to the people has also enabled them to opt for advanced technologies and equipment that provide better results after the surgical procedure has been conducted. The utilization of advanced technologies has enabled potential consumers to have confidence in surgical procedures and techniques. The recent advancements that have taken place after the outbreak of the pandemic have helped to boost the market for stents.
• Increasing demand for surgical procedures - a gradual increase has been observed and the demand for advanced surgical procedures that make use of minimally invasive surgical methods. The modern equipment and devices that are utilized for conducting various surgical procedures related to the cardiovascular system have boosted the market for stents. A huge number of patients belonging to the geriatric population prefer to opt for surgical procedures as they do not have much time to wait for the action of the medicines on the body. The patient is suffering with severe blockages due to high cholesterol levels requiring surgical procedures which emerges as a major opportunity for the growth of the market during the forecast period. A huge number of people all over the world are suffering with severe cardiovascular diseases which emerges as a great opportunity for the growth of the market in the long run.

Key Market Opportunities

• Unhealthy lifestyle - As a result of modern lifestyle practices and sedentary habits the health of people has severely deteriorated. The number of patients suffering with cardiovascular disorders has increased rapidly over period of time. Patients suffering with major blockages require the utilization of advanced stents which help to boost the market to a great extent. A stressful work schedule and busy lifestyle have majorly impacted the cardiac health of the people which in turn emerges as a major opportunity for the growth of the stent market.
• Non-invasive procedures - The increasing demand for minimally invasive surgical procedures and management has boosted the demand for advanced stents. The utilization of minimally invasive surgical procedures proves to be beneficial for the healing process but usually requires a very long period of time. The non-invasive surgical procedures proved to be beneficial for patients who are suffering with diabetes as the healing process is faster. The increasing demand for modern technologies in the healthcare sector all over the world has also proved to be a great opportunity for the growth of the stents market.

Key Market Challenges

• Unfavorable government regulations - The various rules and regulations that are related to the development of modern technologies have hindered the growth of the stent market to a great extent. The unfavorable government regulations and guidelines prove to be an obstacle for the growth of the market in the long run. These obstacles have been experienced in the way of insurance coverage and taxes that make it difficult for the common people to opt for modern technologies.

Product Insights

Based on product, the coronary stent segment accounted highest market share in 2024 as the cases of businesses associated with the heart have increased in recent years period the availability of advanced technology will also boost the market growth in the coming years.

Apart from the growth of the coronary stents segment the peripheral stents segment is also expected to show significant growth during the coming years. An increase in the cases of disease of the peripheral artery will also play a significant role in the growth of the market. The failure of various organs in the human body has created more demand for implants of those organs due to which the need for the stains related to those implants have also increased in recent years and they shall also help in the growth of the market during the forecast period. It will show significant growth in many developed as well as developing economies of the world due to the availability of surgical procedures that make use of advanced technologies.

Material Insights

The metallic segment has dominated the market in 2024 and most of the manufacturers in this industry are increasing their focus on the production of the stents used for cardiovascular diseases. The use of these metallic stents will increase as the cases of endoscopy and fluoroscopy have increased.

Apart from the growth of the metallic materials segment, the growth of the polymeric bio-materials segment is also expected in the coming years. The demand for polymeric stents has increased due to the increasing cases of cardiovascular diseases as the approvals sought from the government for this type of stent have also grown and the market is expected to grow well.

End User Insights

based on the end user, the segment of the hospital has emerged as the largest segment as most of the procedures are carried out within a hospital setup. A hospital setup provides multiple facilities to the patients as well as the medical staff and hence most people opt for the hospital sector for carrying out these surgical procedures. It is extremely essential to monitor the other vital parameters of the patient during the procedure, which is possible only within a hospital setup. Ambulatory surgical center segments will also show significant growth. As a result of the availability of multiple facilities within the hospitals, there shall be significant growth in these treatments in the hospitals.

Regional Insights

U.S. Stents Market Size and Growth 2025 to 2034

The U.S. stents market size is estimated at USD 4.47 billion in 2025 and is expected to be worth around USD 7.92 billion by 2034, rising at a CAGR of 6.53% from 2024 to 2034.

North America dominated the stents market in 2024. The growth of the market is attributed to the rising cardiovascular disease in the countries in the United States, and Canada due to the changing lifestyle preferences, increasing consumption of alcohol and smoking, eating junk are contributing to the increased number of cardiovascular disease in the population that boosts the demand for the cardiovascular treatment and drives the growth of the stents market in the region.

U.S. Stents Market Trends

The U.S. market is experiencing moderate growth, with projected revenues rising steadily over the coming years. Key drivers include the high prevalence of cardiovascular disease and increasing demand for minimally invasive interventions such as percutaneous coronary procedures. Technological innovation is prominent, especially in drug-eluting stents, bioresorbable materials, and improved delivery systems, which are reshaping the competitive landscape. Hospitals continue to dominate end-use segments, while non-vascular stents and peripheral vascular applications are gaining attention as future opportunities.

• There are 4.8% of adults in the United States are diagnosed with coronary heart disease in 2024.
• There are 13.0 million visits to physician offices with chronic ischemic heart disease and coronary atherosclerosis for the primary diagnosis
• Coronary heart disease (CHD) is most prevalent type of heart disease with mortality rate of 375,476 people annually.
• There are more than 795,000 people having stroke every year in the United States, with mortality number of 159,000 Americans each year.

The region of Europe has also proved to be a rising market for stents as a result of the advanced healthcare services that are provided to the people by the government. The people belonging to the region of Europe make use of modern healthcare services and hence demand advanced surgical options with the utilization of modern equipment.

What made Europe the fastest growing region in the stents market in 2025?

Europe experienced rapid growth in the stents market due to a strong clinical research network, expanding capacity at hospitals, and the rising popularity of minimally invasive surgeries. Europe focused on sustainable, bioresorbable, and drug-eluting stents, which represented real value to patient recovery. Supported by favorable EU healthcare regulations, grants for medical innovation, and technology solutions that presented real value to patient care, expansion opportunities blossomed. Moreover, the countries in this region expanded with developments in AI-integrated stent monitoring systems and collaborations to connect hospitals with medtech startups across borders.

Germany Stents Market Trends

Germany was the dominant player in Europe's stent market, owing to successful, advanced hospitals, a substantial base of medical research, and a focus on innovation. A large base of skilled cardiologists working domestically with medical device manufacturers such as Biotronik spurred development and growth in the stents category. The size of healthcare funding for R&D and immense export market potential made Germany a major hub for producing new generation stents and also fused reliability and precision for cardiac intervention implants throughout Europe.

Asia-Pacific: The Beating Heart of Global Expansion

The Asia-Pacific region saw significant growth, driven by urbanization and the increasing size of the aging population and heart disease rates. The countries with improved healthcare access rates - especially China and India - and low-cost manufacturing resulted in expanded stent adoption, driven by supportive governmental initiatives and medical tourism within the region. Additional opportunities included - AI-assisted diagnostics, 3D printed stents, and lower-cost drug-eluting stents developed for local markets to address growing needs to treat cardiac conditions.

China Stents Market Trends

With its sizable population and the number of individuals with heart disease, China represented the largest stent market in the Asia-Pacific region. The government made supporting stent manufacturing in-country appealing as a strategy to lower stent costs and be less dependent on the importation of stents. MicroPort is an example of a company that provides high-quality stents to national and global markets. Furthermore, ongoing investment in R&D and clinical trials provided China with the ability to be a leading producer and consumer of advanced cardiovascular devices.

Latin America: The Reawakening Artery of Innovation

Latin America demonstrated potential growth through improvements in access to health care systems, hospital infrastructure, and government plans focused on lowering cardiovascular death rates through advances in treatments and importing stents. One of the priorities for the cooperation of public-private entities was capitalizing on modern advances in surgical spaces. The rise of a middle class with access to greater income and an understanding of resources available allowed for this market to expand. A few advantages in the market include vertical manufacturing, cross-border supply lines, and training initiatives for interventional cardiologists.

Brazil Stents Market Trends

Brazil represents the largest market for stents in Latin America due to the quality cardiac centers and the implementation of more progressive healthcare policies. Government-sponsored innovation programs to stimulate local markets and a stronghold on domestic manufacturing of high-quality stents mean that Brazil’s adoption of higher-quality stents is robust. Moreover, importation and joint venture partnerships with larger global companies supported technology transfer and the affordability of these resources. Brazil’s patient population base and expanding insurance coverage position Brazil as the central hub for both production and utilization of stents throughout Latin America.

Middle East & Africa: The Oasis of Advanced Cardiology

The Middle East & Africa stents market has developed considerably, driven by the expansion of hospitals, medical tourism, and the rising prevalence of cardiovascular diseases. Governments have invested in modern medical infrastructure to care for their population and imported stents in order to treat patients who would otherwise not achieve optimal outcomes with older stent designs. Increased awareness of minimally invasive procedures has also driven adoption itself. There are also opportunities for regional manufacturing hubs, as well as programs to train skilled interventional cardiologists in developing countries.

The UAE Stents Market Trends

The UAE dominated the regional stent market due to its advanced hospitals, extensive medical tourism, and governmental healthcare support. Partnerships with global medtech companies have also brought innovative stent technologies in the near past. Investments in R&D and world-class cardiac facilities have helped the UAE represent a top country for cardiac care in the Middle East.

Stents Market Companies

• Medtronic plc
• Cook Medical
• B. Braun Melsungen AG
• Terumo Corporation
• Vascular Concepts
• STENTYS SA
• MicroPort Scientific Corporation
• Meril Life Sciences Pvt. Ltd
• Translumina
• Biosensors International Group Limited
• Abbott
• Boston Scientific Corporation
• BIOTRONIK SE & Co. KG

Latest Announcements by Industry Leaders

• MD, Shabana Shahanavaz, director of the Cardiac Catheterization Laboratory at Cincinnati Children's, confirmed his remark about the FDA approval of Renata Minima stent in August 2024. In the course of her 15 years as an interventional cardiologist, Shahanavaz has hailed this technology, which allows dilatation to a normal adult size once implanted in an infant, as groundbreaking. This is the very first stent that is meant to be used for babies only.

Recent Developments:

• In December 2024, Fluid Biomed Inc. wrapped up a $27 million Series A equity financing, co-led by Amplitude Ventures and one of its major strategic partners, and new investors including IAG Capital Partners, LifeArc Ventures, ShangBay Capital, and METIS Innovative.
• In May 2024, A new line of production in India launched by Abbott-the XIENCE Sierra-named everolimus-eluting coronary stent system after the approval from the Central. Drugs Standard Control Organization in February. It is the latest generation in everolimus-eluting coronary stent systems, XIENCE family.

Segments Covered in the Report

By Product

• Peripheral stents
• Coronary stents
• Stent related implants

By Material

• Metallic biomaterial
• Polymer biomaterial
• Natural Biomaterial

By End User

• Hospitals
• Ambulatory surgical centers
• Others

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)